A Collective Vision For Better Cancer Therapy

SAGE Leadership Business

Chris Apfel, MD

Founder, CEO & Chair

William Cance, MD

Board Director
& Advisory Board Chair

Scott Minick

Board Director

William Werkmeister

Board Director

Eyal Granit

Board Observer

SAGE Lab Leadership

Brigitte Apfel, MD

Co-Founder, Treasurer & HR

John Fruehauf, MD

Chief Medical Officer

Ricardo Parker, PHD

Director Cancer Research

Amanda Natalizio, PHD

Director Lab Compliance

Gerald Weiss, MD

Laboratory Director

SAGE Advisory Board

Jörg Dietrich, MD

Scientific Advisory Board

Archelle Georgiou, MD

Strategic Advisor

Amer Karam, MD

Strategic Advisor

Scott Kopetz, MD

Strategic Advisor

Mika Newton

Strategic Advisor

Dr. Michael Seiden, MD

Strategic Advisor

Konstantinos Votanopoulous, MD

Strategic Advisor

Jeffrey Venstrom, MD

Strategic Advisor

The SageMedic Story

SageMedic Corp. was founded by Dr. Chris Apfel and his wife Dr. Brigitte Apfel, both California licensed physicians. While Dr. C. Apfel’s clinical research work in preoperative care has changed clinical practice worldwide, he was disappointed to see that even today cancer treatment has still a long way to go. First, his mother lost her battle to painful ovarian cancer. While watching her ordeal, his father declined anti-cancer therapy when he was diagnosed with lung cancer, and subsequently succumbed to the disease.

This experience drove him to find more effective therapies for cancer patients. He left the clinical department at University of California, San Francisco, received an MBA from Wharton to compliment his scientific education. He also became a life science impact investor and subsequently, the SAGE Oncotest™ was born.

SageMedic is now a registered California lab that is fully accredited in accordance with the Clinical Laboratory Improvement Amendments (CLIA) by the Commission on Office Laboratory Accreditation (COLA) and Center for Medicare and Medicaid Services (CMS). Now SAGE can begin commercializing the Oncotest™ to generate early revenue and clinical case studies.

If making a huge difference intrigues you, please reach out to join us as an impact investor, collaborator, scientist, advisor, consultant, patient advocate, or just to learn more.

Loading...